The Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) is a study comparing sitagliptin with placebo in diabetic patients with a previous history of cardiovascular disease
It has been proved through in vitro thrombosis model and calculation simulation that under the condition of arterial blood flow, blocking GPVI with Fab fragment (ACT017) can promote the effective decomposition of thrombus formed on collagen or human atherosclerotic plaque materials, and its effect increases with the increase of shear rate of vascular wall
They provide calories and basic nutrition without triggering additional GI stimulation
Time and Frequency: Some patients may find the weekly injection easier to manage because it requires less frequent administration
This information supports provider conversations about personalized expectations and monitoring, though it doesn't guarantee specific outcomes
Gather your supplies This includes: Victoza pen (double-check to make sure it is your pen and the liquid inside is clear and colorless) A new, sterile needle for the injection An alcohol swab to clean the injection site Gauze pad or cotton ball A sharps disposal container 2